119699-81-9

Basic information

• Product Name: Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]
• Synonyms: Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime];6-O-Methyl-2',4'-bis-O-(trimethylsilyl)erythromycin 9-[O-(1-methoxy-1-methylethyl)oxime]
• CAS NO: 119699-81-9
• Molecular Formula: C₄₈H₉₄N₂O₁₄Si₂
• Molecular Weight: 979.443
• Mol File: 119699-81-9.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 830.0±75.0 °C(Predicted)
• Appearance: /
• Density: 1.11
• PKA: 13.15±0.70(Predicted)
• CAS DataBase Reference: Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime](CAS DataBase Reference)
• NIST Chemistry Reference: Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime](119699-81-9)
• EPA Substance Registry System: Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime](119699-81-9)

Safety Data

• Hazardous Substances Data: 119699-81-9(Hazardous Substances Data)

Usage

Description

Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] is a chemical compound derived from the antibiotic erythromycin A. It is characterized by its unique structure, which includes a 6-O-methyl group, two trimethylsilyl groups at the 2' and 4' positions, and a 9-[O-(1-methoxy-1-methylethyl)oxime] group. Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] is known for its potential applications in the pharmaceutical industry, particularly in the development of new antibiotics and their derivatives.

Uses

Used in Pharmaceutical Industry:
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] is used as a key intermediate in the synthesis of the antibiotic erythromycin A and its derivatives. The compound plays a crucial role in the development of new antibiotics with improved properties, such as enhanced efficacy, reduced side effects, and increased resistance to bacterial resistance mechanisms.
The compound's unique structure allows for the modification and optimization of erythromycin A, leading to the creation of more effective and targeted antibiotics. This is particularly important in the current global context, where the rise of antibiotic-resistant bacteria poses a significant threat to public health.
In addition to its use in the development of new antibiotics, Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] may also find applications in other areas of the pharmaceutical industry, such as the synthesis of other therapeutic agents or the development of drug delivery systems.

Downstream Products

• 81103-11-9 clarithromycin